Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer

Clinical trial NCT07216248 · RECRUITING

Trial details

NCT number: NCT07216248
Sponsor: University of Utah
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Start date: 2025-10-27
Primary completion: 2030-10-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.